Literature DB >> 21112221

Mesial temporal lobe epilepsy with hippocampal sclerosis: study of 42 children.

Ricardo Cersósimo1, Santiago Flesler, Marcelo Bartuluchi, Ana María Soprano, Hugo Pomata, Roberto Caraballo.   

Abstract

PURPOSE: We present the electroclinical features, treatment, and evolution of patients with mesial temporal lobe epilepsy with hippocampal sclerosis (MTLE-HS).
MATERIAL AND METHODS: We analyzed the charts of forty-two patients who met the diagnostic criteria of MTLE-HS. The mean follow-up after seizure onset was 10.5 years.
RESULTS: According to age, we defined three groups. The first group included nine patients that started with seizures before 2 years of age. Motor seizures were the hallmark clinical manifestation. All patients of this group also presented with motor arrest and oro-alimentary automatisms. In three of them, the interictal EEG recordings showed bilateral paroxysms predominantly in anterior regions, in addition to focal abnormalities, and two had an apparently generalized ictal pattern. The second group included 17 patients that started with seizures between 2 and 10 years of age. In this group the automatisms were also oroalimentary, but more complex and the patients had less motor manifestations. The interictal EEG recordings showed temporal abnormalities. The ictal EEG recordings showed lateralized abnormalities with a maximum in the temporal electrodes. The third group included 16 patients that started with seizures between 10 and 16 years of age. The most common clinical manifestation was abdominal aura followed by oroalimentary, gestural, and verbal automatisms. The interictal and ictal EEG recordings showed well-localized abnormalities in temporal lobes. Thirty-eight patients underwent surgical treatment. Thirty-five patients are seizure free.
CONCLUSION: MTLE-HS represents a well-defined and distinct symptomatic epileptic syndrome. Surgical treatment was successful in most patients.
Copyright © 2010 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21112221     DOI: 10.1016/j.seizure.2010.11.002

Source DB:  PubMed          Journal:  Seizure        ISSN: 1059-1311            Impact factor:   3.184


  6 in total

Review 1.  Preoperative evaluation and surgical decision-making in pediatric epilepsy surgery.

Authors:  Katrina Ducis; Jian Guan; Michael Karsy; Robert J Bollo
Journal:  Transl Pediatr       Date:  2016-07

2.  Predicting novel histopathological microlesions in human epileptic brain through transcriptional clustering.

Authors:  Fabien Dachet; Shruti Bagla; Gal Keren-Aviram; Andrew Morton; Karina Balan; Laleh Saadat; Tibor Valyi-Nagy; William Kupsky; Fei Song; Edward Dratz; Jeffrey A Loeb
Journal:  Brain       Date:  2014-12-16       Impact factor: 13.501

3.  Altered S100 Calcium-Binding Protein B and Matrix Metallopeptidase 9 as Biomarkers of Mesial Temporal Lobe Epilepsy with Hippocampus Sclerosis.

Authors:  Nagwa A Meguid; Hatem Samir; Geir Bjørklund; Mona Anwar; Adel Hashish; Farouk Koura; Salvatore Chirumbolo; Saher Hashem; Mona A El-Bana; Hebatalla S Hashem
Journal:  J Mol Neurosci       Date:  2018-10-20       Impact factor: 3.444

4.  Administration of simvastatin after kainic acid-induced status epilepticus restrains chronic temporal lobe epilepsy.

Authors:  Chuncheng Xie; Jiahang Sun; Weidong Qiao; Dunyue Lu; Lanlan Wei; Meng Na; Yuanyuan Song; Xiaohua Hou; Zhiguo Lin
Journal:  PLoS One       Date:  2011-09-19       Impact factor: 3.240

5.  Mutations in GABRG2 receptor gene are not a major factor in the pathogenesis of mesial temporal lobe epilepsy in Indian population.

Authors:  Aparna Banerjee Dixit; Jyotirmoy Banerjee; Abuzar Ansari; Manjari Tripathi; Sarat P Chandra
Journal:  Ann Indian Acad Neurol       Date:  2016 Apr-Jun       Impact factor: 1.383

Review 6.  Hippocampal Pathophysiology: Commonality Shared by Temporal Lobe Epilepsy and Psychiatric Disorders.

Authors:  Soichiro Nakahara; Megumi Adachi; Hiroyuki Ito; Mitsuyuki Matsumoto; Katsunori Tajinda; Theo G M van Erp
Journal:  Neurosci J       Date:  2018-01-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.